This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Teva-Galantamine ER (2013-12-12)
- Starting date:
- December 12, 2013
- Posting date:
- January 3, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-37377
Recalled Products
Teva-Galantamine ER
Reason
Potential for product to not meet its stability dissolution specifications.
Depth of distribution
Retailers in Alberta, British Columbia, Saskatchewan, Manitoba, Ontario, Quebec, Newfoundland, New Brunswick, Nova Scotia.
Affected products
Teva-Galantamine ER
DIN, NPN, DIN-HIM
DIN 02377977
Dosage form
Extended Release Capsule
Strength
24 mg
Lot or serial number
G82004
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA